Fundraising Fox
Find your path to Dayton
Sign up to see every warm intro you have to Dayton
- Paths you didn't know you had: your email and LinkedIn already hold routes to Dayton. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Dayton Misfeldt is a Partner at Decheng Capital, which he joined in January 2021. He was previously a Managing Director at Bay City Capital, where he invested in biopharmaceutical companies and supported management teams on strategy, business development, and exits, and earlier worked as a sell-side analyst at Roth Capital Partners and in consulting at LifeScience Economics. He holds a BA in Economics from the University of California, San Diego.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Board seats
ExcellergyUpstream Bio
Investor
Cadence PharmaceuticalsCivitas TherapeuticsDermiraExcellergyMAP PharmaceuticalsNextwave PharmaceuticalsOculex PharmaceuticalsPharmion
Per the firm's website.
Colleagues at Decheng Capital
Frequently asked questions
- Who is Dayton Misfeldt?
- Dayton Misfeldt is a Partner at Decheng Capital, which he joined in January 2021. He was previously a Managing Director at Bay City Capital, where he invested in biopharmaceutical companies and supported management teams on strategy, business development, and exits, and earlier worked as a sell-side analyst at Roth Capital Partners and in consulting at LifeScience Economics. He holds a BA in Economics from the University of California, San Diego.
- Where does Dayton Misfeldt work?
- Dayton Misfeldt is Partner at Decheng Capital.
- What does Dayton Misfeldt invest in?
- Dayton Misfeldt invests in Biotech.
- What boards does Dayton Misfeldt sit on?
- Dayton Misfeldt holds tracked board seats at Excellergy, Upstream Bio.
- What companies has Dayton Misfeldt invested in?
- Investments tracked here include Cadence Pharmaceuticals, Civitas Therapeutics, Dermira, Excellergy, MAP Pharmaceuticals, Nextwave Pharmaceuticals, Oculex Pharmaceuticals, Pharmion.
About this profile. Compiled from public sources — Decheng Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights